Literature DB >> 20188726

Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats.

Harikesh Kalonia1, Puneet Kumar, Anil Kumar.   

Abstract

Objective of the present study was to explore the possible role of oxidative stress in the malonic acid induced behavioral, biochemical and mitochondrial alterations in rats. In the present study, unilateral single injections of malonic acid at different doses (1.5, 3 and 6 micromol) were made into the ipsilateral striatum in rats. Behavioral parameters were accessed on 1st, 7th and 14th day post malonic acid administration. Oxidative stress parameters and mitochondrial enzyme functions were assessed on day 14 after behavioral observations. Ipsilateral striatal malonic acid (3 and 6 micromol) administration significantly reduced body weight, locomotor activity, motor coordination and caused oxidative damage (lipid peroxidation, nitrite, superoxide dismutase, catalase and glutathione) in the striatum as compared to sham treated animal. Mitochondrial enzyme complexes and MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolinium bromide) activity were significantly inhibited by malonic acid. Vitamin E treatment (50 and 100 mg/kg, p.o.) significantly reversed the various behavioral, biochemical and mitochondrial alterations in malonic acid treated animals. Our findings show that targeting oxidative stress by vitamin E in malonic acid model, results in amelioration of behavioral and mitochondrial alterations are linked to inhibition of oxidative damage. Based upon these finding present study hypothesize that protection exerted by vitamin E on behavioral, mitochondrial markers indicates the possible preservation of the functional status of the striatal neurons by targeting the deleterious actions of oxidative stress. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188726     DOI: 10.1016/j.ejphar.2010.02.031

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

Review 1.  Antioxidants in Huntington's disease.

Authors:  Ashu Johri; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2011-11-23

Review 2.  Prospects for cannabinoid therapies in basal ganglia disorders.

Authors:  Javier Fernández-Ruiz; Miguel Moreno-Martet; Carmen Rodríguez-Cueto; Cristina Palomo-Garo; María Gómez-Cañas; Sara Valdeolivas; Carmen Guaza; Julián Romero; Manuel Guzmán; Raphael Mechoulam; José A Ramos
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

3.  Tolfenamic acid inhibits ROS-generating oxidase Nox1-regulated p53 activity in intrastriatal injection of malonic acid rats.

Authors:  Xin Yang; Heling Zhang; Tong Qu; Yi Wang; Yongxian Zhong; Yuchen Yan; Xuefei Ji; Tiayan Chi; Peng Liu; Libo Zou
Journal:  J Physiol Sci       Date:  2022-07-18       Impact factor: 2.257

4.  Neurodegeneration Alters Metabolic Profile and Sirt 1 Signaling in High-Fat-Induced Obese Mice.

Authors:  Leandro Ceotto Freitas Lima; Soraya Wilke Saliba; João Marcus Oliveira Andrade; Maria Luisa Cunha; Puebla Cassini-Vieira; John David Feltenberger; Lucíola Silva Barcelos; André Luiz Sena Guimarães; Alfredo Mauricio Batista de-Paula; Antônio Carlos Pinheiro de Oliveira; Sérgio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2016-05-16       Impact factor: 5.590

5.  Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment.

Authors:  Mei Zheng; Yujie Shi; Dongsheng Fan
Journal:  Neural Regen Res       Date:  2013-12-15       Impact factor: 5.135

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.